Seminar: "From Human iPSC-based Models to Therapeutics: the iPierian Story"


Dr. Nancy Stagliano, Chief Executive Officer, True North Therapeutics, Inc. Host: Dennis Clegg
Dr. Nancy Stagliano Host: Dennis Clegg

Date and Location

Wednesday November 04, 2015 11:00am to 12:00pm
1605 Elings


Nancy Stagliano, Ph.D. is currently Chief Executive Officer and co-founder of True North Therapeutics, a rare disease therapeutics company working in the classical complement pathway. Dr. Stagliano has an accomplished career as a biotech leader spanning all aspects of the industry, from company building, discovery research and strategy to global medical affairs and corporate communications.  Previously, Dr. Stagliano was CEO of iPierian, Inc. which applied human iPSCs to model neurodegenerative diseases. The company and its lead antibody program against Tau for the treatment of PSP and Alzheimer’s disease. She will describe how induced pluripotent stem cells can be used to model disease and develop novel therapeutics.